← Back to Search

Phototherapy

Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis

N/A
Waitlist Available
Research Sponsored by Illumicure Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2, 4, 22 and 30 weeks
Awards & highlights
No Placebo-Only Group

Summary

This is a proof of concept, investigator blinded study to evaluate the efficacy and safety of a novel combination of a home narrow band ultraviolet B (NBUVB) lamp with an occlusive dressing in adult subjects with mild to moderate psoriasis vulgaris. Two interpatient arms will be used to compare the efficacy of combination of NBUVB with an occlusive dressing (active) to no treatment (control). 32 patients will be enrolled in this 30 week study.

Eligible Conditions
  • Psoriasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2, 4, 22 and 30 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2, 4, 22 and 30 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Target Plaque Assessment (TPA) at 6 weeks
Secondary study objectives
Compliance
Duration of remission
Frequency and severity of device and / or procedure related adverse events
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Luma Light SystemExperimental Treatment1 Intervention
The experimental arm will be a combination of an occlusive dressing and NBUVB light.
Group II: Non-treatment ControlActive Control1 Intervention
Control arm will not have any intervention

Find a Location

Who is running the clinical trial?

Illumicure IncLead Sponsor
1 Previous Clinical Trials
10 Total Patients Enrolled
1 Trials studying Psoriasis
10 Patients Enrolled for Psoriasis
~4 spots leftby Dec 2025